Full Press Release Details
BOSTON, May 18, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that management will be presenting at the H.C. Wainwright Global Investment Conference, taking place May 23-26, 2022, and the Jefferies Global Healthcare Conference, taking place June 8-10, 2022.
Ikena CEO Mark Manfredi, Ph.D., will present a corporate update at the H.C. Wainwright Global Investment Conference and management will attend virtually. They will also participate in a fireside chat at the Jefferies Global Healthcare Conference and will attend the conference live in New York City.
Details can be found below:
| H.C Wainwright Global Investment Conference |
| Corporate Presentation |
| Date: May 25, 2022, 11:30 a.m. ET |
| Webcast Link |
| Jefferies Global Healthcare Conference |
| Fireside Chat |
| Date: June 9, 2022, 10:00 a.m. ET |
| Webcast Link |
The presentation webcasts will be available on the Company’s Events & Presentations page on their website at www.ikenaoncology.com.
About Ikena Oncology
LifeSci Communications